Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: A contemporary analysis
Diabetic Medicine | Mar 20, 2019
Survival and predictors of outcome amongst patients with decompensated liver disease in a non-liver transplant ICU. Pessimism is historical and unjustified
Internal Medicine Journal | Mar 20, 2019
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial
Diabetes, Obesity and Metabolism | Mar 20, 2019
Efficacy and safety of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase 3, open-label, 2:1 randomized, treat-to-target trial
Diabetes, Obesity and Metabolism | Mar 20, 2019
Glycemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting
Diabetes, Obesity and Metabolism | Mar 20, 2019
Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin
Diabetes, Obesity and Metabolism | Mar 20, 2019
Effects of lixisenatide on postprandial blood pressure, gastric emptying, and glycemia in healthy people and people with type 2 diabetes
Diabetes, Obesity and Metabolism | Mar 20, 2019
Metformin attenuates the postprandial fall in blood pressure in type 2 diabetes
Diabetes, Obesity and Metabolism | Mar 20, 2019
Statins and pancreatic cancer risk in patients with chronic pancreatitis: A Danish nationwide population-based cohort study
International Journal of Cancer | Mar 19, 2019
Therapy-related cardiac risk in childhood cancer survivors: An analysis of the childhood cancer survivor study
Journal of Clinical Oncology | Mar 18, 2019